Zai Lab - Stock Price History | ZLAB

Historical daily share price chart and data for Zai Lab since 2021 adjusted for splits. The latest closing stock price for Zai Lab as of September 24, 2021 is 119.86.
  • The all-time high Zai Lab stock closing price was 191.71 on January 20, 2021.
  • The Zai Lab 52-week high stock price is 193.54, which is 61.5% above the current share price.
  • The Zai Lab 52-week low stock price is 79.64, which is 33.6% below the current share price.
  • The average Zai Lab stock price for the last 52 weeks is 139.84.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Zai Lab Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 75.6760 42.6200 135.3400 39.1000 135.3400 225.41%
2019 32.0775 22.3000 43.0600 21.7100 41.5900 79.11%
2018 21.1106 22.2600 26.9600 14.9500 23.2200 9.37%
2017 26.7446 27.9300 34.0900 21.2300 21.2300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.532B $0.049B
Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71